New Medication: Aripiprazole 400mg Prolonged-Release Injection

posted Jun 10, 2019, 7:38 PM by Muhammad Fikree Ahmad   [ updated Jun 10, 2019, 7:42 PM ]
4 June 2019 (Circular No. SP PPUM: 238/2019)

Based on the outcome of Drug and Therapeutics Subcommittee Meeting (No. 1/2019), the following medication has been accepted to be in UMMC Formulary.

Product Name

:

Abilify Maintena

Active Ingredient

:

Aripiprazole Monohydrate

Strength

:

400mg

Dosage Form

:

Prolonged-Release Injection

Registration No.

:

MAL18026186AZ

Holder

:

Lundbeck Malaysia Sdn. Bhd.

Manufacturer

:

Otsuka Pharmaceutical Co., Ltd.

Prescriber

:

Psychiatrist

Formulary Category

:

Special

Restrictions

:

For maintenance treatment of schizophrenia in adults